June 15, 2022
The Senate Committee on Health, Education, Labor, and Pension (HELP) has passed the FDA Safety and Landmark Advancement Act (FDASLA) in a 13-9 vote.
June 10, 2022
A Rhode Island bill (S. 2613) that would restrict access to weight management and sports nutrition supplements to those under the age of 18 has passed the state’s Senate by a vote of 33 to 4.
June 09, 2022
The U.S. Hemp Authority released a draft Version 4.0 of the standard for its Certification Program for public comment.
June 08, 2022
FDASLA would establish a mandatory product listing requirement for dietary supplements.
June 07, 2022
The report assessed isolated melatonin ingestions among children, adolescents, and young adults 19 years and under between January 1, 2012, and December 31, 2021 using the American Association of Poison Control Centers’ National Poison Data System (NPDS).
The branded ingredient is natural and standardized to 95% fisetin.
June 06, 2022
FDA has sent warning letters to four companies for selling “unapproved animal drugs containing cannabidiol (CBD)” that are marketed for use in food-producing animals.
June 03, 2022
The new webpage, called Supplement Your Knowledge, includes informational sheets advising the public about what to consider when purchasing or prescribing supplements, warnings about safe usage, and information about how FDA regulates supplements.
June 01, 2022
The National Advertising Division of BBB National Programs recommended Goli discontinue claims regarding sexual function, weight loss and management, and physical performance after reviewing Goli’s evidence and determining that much of it was not sufficient to support its claims.
May 31, 2022
Newly proposed legislation is driving the urgency to build support for or against mandatory product listing. What are the topline arguments?